In the context of concurrent deletions of KLF5 and PTEN in human prostate cancer, our findings further suggest that during the development of human prostate cancer, KLF5 loss and PTEN loss cooperate to enhance tumor angiogenesis by upregulating HIF1α and VEGF, which remains to be examined. This evidence concerns the gene KLF5 and neoplasm.